Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

FDA approves first new ALS drug in 22 years

The US FDA has recently approved Radicava, the first new drug to treat patients with amyotrophic lateral sclerosis (ALS) in over two...

FDA approves first new ALS drug in 22 years
GlobalData Healthcare

The Three-Pronged Strategy to Combat NASH

The Three-Pronged Strategy to Combat NASH
GlobalData Healthcare

The death of medicine

The death of medicine
GlobalData Healthcare

Will acne be the next indication to benefit from biologics?

Will acne be the next indication to benefit from biologics?
GlobalData Healthcare

Get Granular, Beat Cancer

Get Granular, Beat Cancer

Company Releases »

Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Sartorius
Biopharmaceutical Laboratory Equipment and Integrated Bioprocess Services

Studying Biophysical Applications of Calorimetric Methods

Malvern Instruments
Studying Biophysical Applications of Calorimetric Methods

Analysing Polysaccharides Using OMNISEC

Malvern Instruments Analysing Polysaccharides Using OMNISEC

Biopharmaceutical and Drug Development

Malvern Instruments
Biopharmaceutical and Drug Development

Application: Operating Reactor Systems for Process Research and Development

SYSTAG Systems Technik Application: Operating Reactor Systems for Process Research and Development

Drugdevelopment Insights »

Drugdevelopment Industry Reports »

Burden of Diabetic Foot Ulcers

Burden of Diabetic Foot Ulcers

Importance of reducing the risk for Hepatitis C virus infection

Importance of reducing the risk for Hepatitis C virus infection

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115